X @The Wall Street Journal
The Wall Street Journal·2026-01-28 16:36
While nearly 18% of U.S. adults have taken a GLP-1 drug for weight loss or to treat a chronic condition, about half of people will stop taking it within a year. Often, they don’t understand what is likely to come next.Read more from Sumathi Reddy: 🔗 https://t.co/xzFKhuvX7z https://t.co/hWku2IEFVS ...